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        Introduction 
  Traditionally, cadherins have been studied for their central role 
in cell – cell adhesion. They comprise a superfamily of transmem-
brane proteins that link adjacent cells via calcium-dependent 
homophilic interactions (  Yagi and Takeichi, 2000  ). A group 
of cytoplasmic proteins, the catenins, interact with and modu-
late cadherins at two highly conserved intracellular domains. 
    -Catenin associates with the most C-terminal conserved domain 
and is responsible for indirectly inducing the reorganization of 
the actin cytoskeleton (  Gottardi and Gumbiner, 2001  ). p120 
catenin (herein, p120), however, binds to the juxtamembrane 
domain (  Yap et al., 1998  ;   Thoreson et al., 2000  ) and is critical 
for cadherin stability and turnover (  Ireton et al., 2002  ;   Davis 
et al., 2003  ;   Xiao et al., 2003  ). Although cadherins have been 
heavily studied for their vital role in cell adhesion, several stud-
ies have also shown them to be involved in signaling events that 
modulate other cellular processes, including cell migration and 
invasiveness, cell growth, and terminal differentiation (  Behrens 
et al., 1989  ;   Vleminckx et al., 1991  ;   Perl et al., 1998  ;   St. Croix 
et al., 1998  ;   Gottardi et al., 2001  ). 
  Epithelial cadherin (E-cadherin) loss is thought to pro-
mote tumor invasion and metastasis via a mechanism that in-
volves both     -catenin and p120 (  Wong and Gumbiner, 2003  ; 
  Yanagisawa and Anastasiadis, 2006  ). p120 plays a pivotal role 
in these events by either promoting E-cadherin stability and a 
sessile cellular phenotype or by inducing cell migration and 
invasiveness of E-cadherin  –  defi  cient cells through its effects on 
Rho GTPase activities (  Yanagisawa and Anastasiadis, 2006  ; 
  Yanagisawa et al., 2008  ). Rho GTPases are important molecular 
switches that regulate cytoskeletal dynamics, cell migration, 
adhesion, and growth (  Hall, 2005  ). Several studies indicate that 
p120 regulates the activity of Rho family GTPases (including 
RhoA, Rac1, and Cdc42) in a cadherin/adhesion-dependent man-
ner (for review see   Anastasiadis, 2007  ). p120 inhibits RhoA ac-
tivity by suppressing GDP dissociation and therefore activation 
in the cadherin-unbound state (  Anastasiadis et al., 2000  ;   Castano 
et al., 2007  ;   Yanagisawa et al., 2008  ) or by recruiting the negative 
regulator p190 Rho GTPase-activating protein to cadherin com-
plexes (  Wildenberg et al., 2006  ). In addition, p120 overexpres-
sion promotes Rac1 activation in fi  broblasts (  Noren et al., 2000  ; 
  p
120 catenin regulates the activity of the Rho family 
guanosine triphosphatases (including RhoA and 
Rac1) in an adhesion-dependent manner. Through 
this action, p120 promotes a sessile cellular phenotype 
when associated with epithelial cadherin (E-cadherin) or 
a motile phenotype when associated with mesenchymal 
cadherins. In this study, we show that p120 also exerts 
signiﬁ  cant and diametrically opposing effects on tumor cell 
growth depending on E-cadherin expression. Endogenous 
p120 acts to stabilize E-cadherin complexes and to actively 
promote the tumor-suppressive function of E-cadherin, 
potently inhibiting Ras activation. Upon E-cadherin loss 
during tumor progression, the negative regulation of Ras 
is relieved; under these conditions, endogenous p120 pro-
motes transformed cell growth both in vitro and in vivo by 
activating a Rac1  –  mitogen-activated protein kinase sig-
naling pathway normally activated by the adhesion of 
cells to the extracellular matrix. These data indicate that both 
E-cadherin and p120 are important regulators of tumor 
cell growth and imply roles for both proteins in chemo-
resistance and targeted therapeutics.
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ence of E-cadherin. Endogenous p120 promotes the trans-
formed growth of E-cadherin  –  defi  cient tumors by promoting 
Rac1 activation and inducing MAPK signaling. In contrast, 
p120 potently suppresses the growth of tumor cells expressing 
endogenous or exogenous E-cadherin. Furthermore, E-cadherin 
suppresses tumor cell growth in a p120 and Ras-MAPK – dependent 
manner. These data provide important insights into the roles 
of cadherin complexes in general, and p120 in particular, in 
cellular proliferation, anchorage-independent growth, and tu-
mor progression. 
  Results 
  Endogenous p120 induces MDA-MB-231 
tumor growth 
  Previously, we reported that depletion of endogenous p120 in 
E-cadherin – defi  cient MDA-MB-231 cells signifi  cantly reduces 
cell migration and invasiveness and that reexpression of full-
length murine p120 rescues these effects (  Yanagisawa and 
Anastasiadis, 2006  ). We have now used the same retrovirally 
infected stable cell lines to test the hypothesis that endoge-
nous p120 affects tumor cell growth. Initially, we tested the 
ability of p120 to mediate anchorage-independent growth by 
plating MDA-MB-231 cells in soft agar. Control pRS/LZRS-neo  –
  infected MDA-MB-231 cells (pRS) grew well under these con-
ditions (  Fig. 1, A and B  ). 
[ID]FIG1[/ID]  In contrast, p120-depleted cells (p120 
knockdown [KD]) failed to grow under conditions of anchorage 
independence, and this effect was reversed by the expression 
of exogenous murine p120 isoform 1A (p120KD + mp120). 
  Fig. 1 C   shows that when p120-depleted MDA-MB-231 cells 
were plated on plastic, they exhibited a slower growth rate than 
control cells over time, which was signifi  cant at 72 and 96 h. This 
effect was also reversed by ectopic p120 expression, indicating 
that it is not caused by   “  off-target  ”   effects of the p120 short 
hairpin RNA (shRNA). Furthermore, cell cycle analysis using 
fl  ow cytometry indicated that p120-depleted cells exhibit greater 
distribution during either G0  –  G1 or G2  –  M phases of the cell 
cycle and a signifi  cant reduction of cells in the S phase.   Fig. 1 D   
shows that these effects of p120 depletion on the cell cycle were 
also completely reversed by the ectopic expression of murine 
p120 (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200805113/DC1). These data indicate that endogenous p120 
regulates MDA-MB-231 cell growth in vitro  .  
  To test the possibility that p120 also regulates the growth 
of MDA-MB-231 cells in vivo, we injected tumor cells subcu-
taneously in the fl  anks of nude mice (10 injections per cell line) 
and determined tumor growth over a period of 42 d (  Fig. 1 E  ). 
The mean tumor volume increased rapidly in control pRS tu-
mors. In contrast, fl  anks injected with p120-depleted cells ex-
hibited an initial decline in tumor volume, which was followed 
by a very slow tumor growth in only 2 of the 10 injection sites 
(compared with 10 out of 10 for control). Reexpression of p120 
in these cells by the ectopic addition of murine p120 signifi  -
cantly increased tumor volume as well as tumor take (seven 
tumors for 10 injected fl  anks). Collectively, these data indicate 
that endogenous p120 promotes the transformed growth of MDA-
MB-231 breast cancer cells. 
  Grosheva et al., 2001  ), whereas the recruitment and activation 
of Rac1 upon cadherin ligation requires p120 catenin bind-
ing to the cadherin complexes (  Goodwin et al., 2003  ;   Gavard 
et al., 2004  ). As Rho GTPases play critical roles in the for-
mation and maintenance of both cadherin-mediated adherens 
junctions and integrin-mediated focal adhesions, the data argue 
that p120 is a critical intermediary in the cross talk between 
these cellular structures and their respective roles in regulat-
ing the sessile versus motile behavior of cells (for review see 
 Anastasiadis,  2007 ). 
  The effects of either E-cadherin or p120 on cell growth 
are far less understood. Available data show that E-cadherin 
has both positive and negative effects on cell growth. Early 
studies argued that E-cadherin suppresses cell proliferation by 
inhibiting nuclear     -catenin signaling (  Gottardi et al., 2001  ; 
  Stockinger et al., 2001  ). More recently, E-cadherin expression 
was shown to inhibit cell growth via a mechanism that involves 
    -catenin association but not signaling and likely the subse-
quent suppression of receptor tyrosine kinase (RTK) signaling 
(  Perrais et al., 2007  ). Cadherins associate closely with RTKs 
(including the EGF receptor [EGFR], c-erbB2, c-Met, IGFR1, 
VEGF receptor, and FGF receptor), and several studies have un-
covered a complex and intimate relationship in which E-cadherin  –
  mediated cell  –  cell adhesion is either promoted or disrupted 
by RTK signaling or, conversely, in which RTK signaling to 
downstream effectors is either promoted or inhibited by cadherin 
clustering (  Pece and Gutkind, 2000  ;   Comoglio et al., 2003  ; 
  Qian et al., 2004  ;   Lilien and Balsamo, 2005  ). Finally, early stud-
ies suggested that the inhibitory effect of E-cadherin  –  mediated 
adhesion on cell proliferation is mediated by the Cdk inhibitor 
p27 (KIP1;   St. Croix et al., 1998  ;   Motti et al., 2005  ). How-
ever, despite a general agreement that E-cadherin suppresses 
tumor cell migration, the role of E-cadherin as a more classical 
suppressor of tumor growth has not been studied extensively. 
Confounding this effort, recent data indicate that E-cadherin  –
  mediated cell  –  cell adhesion can promote cell proliferation un-
der conditions of low confl  uence via a mechanism that requires 
p120 and Rac1 activation (  Liu et al., 2006  ). Furthermore, in-
creased expression of E-cadherin induces Akt and MAPK sig-
naling and promotes the growth of ovarian carcinomas (  Reddy 
et al., 2005  ). 
  p120 is often mislocalized or lost altogether in human tu-
mors (  Thoreson and Reynolds, 2002  ). These p120 phenotypes 
have been correlated to altered Rho GTPase signaling and in-
creased invasiveness in vitro (  Yanagisawa and Anastasiadis, 
2006  ). The ability of p120 to stabilize cadherin complexes on 
the plasma membrane, to mediate signaling downstream of RTKs 
(c-Met and the PDGF receptor), and to regulate the activity of 
Rho family GTPases suggests that the mislocalization or loss of 
p120 in human cancer may have important implications on tu-
mor cell growth. Interestingly, conditional p120 knockout in 
either the salivary glands or skin of mice induces a hyperprolif-
erative response ( Davis and Reynolds, 2006 ;  Perez-Moreno et al., 
2006  ). In this study, we consider p120  ’  s role in regulating tumor 
cell growth through its effects on Rho GTPases and E-cadherin. 
Our data reveal signifi  cant and diametrically opposing effects of 
endogenous p120 on tumor cell growth depending on the pres-739 DUAL ROLE OF   P  120 ON TRANSFORMED CELL GROWTH   • Soto et al. 
cells to grow tumors when injected in mice (  Fig. 2 D  ). Combined, 
these data strongly argue that endogenous p120 promotes the 
growth of MDA-MB-231 cells by inducing Rac1 activation. 
  The MAPK pathway is essential for 
p120-mediated growth effects 
  Recent data have shown that signifi  cant cross talk exists between 
growth factor signaling and integrin-mediated adhesion to the ex-
tracellular matrix (ECM). More specifi  cally, fi  bronectin-mediated 
activation of Rac1 and its effector p21-activated kinase (PAK) 
have been shown to promote the phosphorylation, increased as-
sociation, and constitutive activation of the Ras  –  Raf  –  MAPK/
ERK kinase (MEK)  –  extracellular signal-regulated kinase (ERK) 
signaling pathway (  Fig. 3 A  ;   Frost et al., 1997  ;   Coles and Shaw, 
2002  ;   Eblen et al., 2002  ;   Slack-Davis et al., 2003  ;   Beeser et al., 
2005 ). 
[ID]FIG3[/ID]  MDA-MB-231 cells, like many tumor cells, can grow un-
der conditions of anchorage independence and exhibit high levels 
of activated Rac1 (  Fig. 2 A  ). The observation that p120 depletion 
blocks both Rac1 activation and growth in soft agar suggested the 
possibility that p120 promotes the anchorage-independent growth 
of MDA-MB-231 cells through the induction of a Rac1  –  PAK  –
 MEK – ERK  signaling  pathway. 
  To test this hypothesis, we initially determined the effects 
of p120 depletion on PAK-specifi  c phosphorylation sites of Raf 
(Ser338) and MEK1/2 (Ser298) as well as on the activation of 
ERK1/2 and the levels of cyclins and Cdk inhibitors.   Fig. 3 B   
shows that depletion of endogenous p120 results in reduced 
  p120 promotes MDA-MB-231 tumor 
growth via activation of Rac1 
 We have previously shown that the depletion of endogenous p120 
in MDA-MB-231 cells results in increased RhoA and reduced 
Rac1 basal activities (  Yanagisawa and Anastasiadis, 2006  ). The 
reexpression of full-length murine p120 isoform 1A (mp120) res-
cues both Rac1 and RhoA activities. In contrast, the expression of 
a p120 truncation mutant lacking 323 N-terminal amino acids ( Δ N) 
and resembling endogenous p120 isoform 4 can rescue Rac1 ac-
tivation (  Fig. 2 A  ) but has no effect on RhoA (  Yanagisawa et al., 
2008 ). 
[ID]FIG2[/ID]  To test the hypothesis that p120 promotes anchorage-inde-
pendent growth via its effects toward Rac1, we initially expressed 
the p120   Δ  N truncation mutant in endogenous p120-depleted 
cells and determined its effect on soft agar growth. As can be seen 
in   Fig. 2 B  , the expression of p120   Δ  N rescued the anchorage-
independent growth of p120-depleted MDA-MB-231 cells, sug-
gesting that the ability of p120 to affect Rac1 but not RhoA is 
important for its effects on MDA-MB-231 cell growth. 
 To directly test this hypothesis, we expressed a constitutively 
active (V12) mutant of Rac1 in p120-depleted MDA-MB-231 
cells (KD + Rac1) and tested its effects on growth in soft agar, cell 
cycle progression, and tumor growth in mice.   Fig. 2 B   shows that 
the expression of constitutively active Rac1 can rescue the anchor-
age-independent growth of p120-depleted cells. Furthermore, Rac1 
activation signifi   cantly reversed cell cycle defects induced by 
p120 depletion (  Figs. 1 D   and   2 C  ). Finally, activation of Rac1 
completely rescued the ability of p120-depleted MDA-MB-231 
  Figure 1.       p120 promotes the transformed growth of MDA-MB-231 cells.   (A and B) MDA-MB-231 cells were infected with control pRS and LZRS-neo retro-
viruses (pRS), p120 shRNA virus together with LZRS-neo (p120KD), or p120 shRNA virus together with a retrovirus expressing murine p120 isoform 1A 
(p120KD + mp120). Stable polyclonal cell populations were generated, and the ability of the cells to grow in soft agar was tested. p120-depleted cells 
(p120KD) were less able to grow in soft agar when compared with control (pRS) cells or cells reexpressing p120 (***, P   <   0.0001; analysis of variance 
[ANOVA]). Data represent the mean   ±   SEM (error bars) of three independent experiments performed in triplicate. (C) The ability of the same cell lines to 
grow on plastic was also determined over time. 1.5   ×   10 
4   cells per well were plated in 24-well plates, and their growth was examined over time by cell 
counting. p120-depleted cells grew slower on plastic (**, P   <   0.001 at 96 h; ANOVA). Mean   ±   SD (error bars;   n   = 9). (D) Cells were ﬁ  xed in ethanol, 
treated with RNase, stained with propidium iodide, and analyzed with ﬂ  ow cytometry for their distribution in the cell cycle. Cells without p120 exhibit a 
G1 and G2 arrest that is rescued by mp120 expression. (E) 10 
6   cells were injected into each ﬂ  ank of nude mice, and tumor growth was monitored over 
time by measuring tumor volume. p120 depletion inhibited MDA-MB-231 tumor growth in nude mice. Results represent the mean   ±   SD (error bars) of 10 
independent determinations.     JCB • VOLUME 183 • NUMBER 4 • 2008  740
shows that neither compound affected the growth of p120-
depleted cells in soft agar. However, U0126 selectively and potently 
inhibited the soft agar growth of cells expressing murine p120. 
These data strongly argue that endogenous p120 promotes the 
growth of MDA-MB-231 cells by activating Rac1 and inducing 
the Rac1-mediated activation of MAPK signaling (  Fig. 3 D  ). 
  E-cadherin expression reverses p120 
oncogenic effects and suppresses 
growth, Rac1, and Ras activity in a 
p120-dependent manner 
  Previous data show that ectopic expression of E-cadherin potently 
antagonizes the ability of endogenous p120 to promote the migra-
tion and invasiveness of MDA-MB-231 cells (  Yanagisawa and 
Anastasiadis, 2006  ). Therefore, we next examined whether 
E-cadherin expression can block the oncogenic effects of p120. 
  Fig. 4 A   shows that ectopic expression of E-cadherin potently 
blocks the growth of MDA-MB-231 cells in soft agar. 
[ID]FIG4[/ID]  To test the 
potential involvement of p120, we examined the effect of p120 
depletion on the growth of cells expressing E-cadherin as well as 
phosphorylation of Raf-Ser338 and MEK-Ser298. Consistent 
with this, p120-depleted cells exhibit reduced ERK phosphory-
lation, reduced levels of cyclin D1, and increased levels of p27/
KIP1. Consistent with their ability to activate Rac1, expression 
of either full-length murine p120 or of the N-terminally truncated 
p120 mutant (  Δ  N) rescued both Raf and MEK phosphorylation 
at these sites, induced activation of ERK1/2, increased expres-
sion of cyclin D1, and inhibited p27. Furthermore, direct activa-
tion of Rac1 in p120-depleted MDA-MB-231 cells by expression 
of constitutively active Rac1 induced the same phosphorylation 
events and activated MAPK signaling ( Fig. 3 B ). These data show 
that the MAPK signaling pathway is severely impaired in p120-
depleted MDA-MB-231 cells and that activation of Rac1 res-
cues MAPK signaling. 
  Next, we examined whether the activation of MAPK sig-
naling by p120 is required for the ability of MDA-MB-231 cells 
to grow in soft agar. To test this, we treated p120-depleted MDA-
MB-231 cells (p120KD) or p120-depleted cells expressing mu-
rine p120 (KD + mp120) with 10   μ  M of the MEK inhibitor 
U0126 or with 10   μ  M of its inactive isomer U0124.   Fig. 3 C   
  Figure 2.       p120 promotes MDA-MB-231 tumor growth via activation of Rac1.   (A) Levels of total and GTP-bound (active) Rac1 were determined in MDA-
MB-231 cells infected with control pRS and LZRS-neo viruses (pRS), p120-depleted cells (p120KD) or cells reexpressing full-length murine p120 (KD + 
mp120), or a RhoA-uncoupled p120 mutant (  Yanagisawa et al., 2008  ) lacking 323 N-terminal amino acids (KD +   Δ  N). The bottom panel shows levels of 
endogenously expressed and exogenous p120. p120-depleted cells exhibited low levels of basal Rac1 activity. Expression of either murine p120 or the     N 
p120 mutant rescued Rac1 activation. (B) The ability of p120-depleted cells (p120KD) or p120-depleted cells stably expressing either the RhoA-uncoupled 
  Δ  N p120 mutant (KD +   Δ  N) or constitutively active V12-Rac1 (KD + Rac1) to grow in soft agar was tested. Data represent the mean   ±   SEM (error bars) of 
three independent determinations performed in triplicate (**, P   <   0.001 as compared with p120KD control; Student  ’  s   t   test). (C) The ability of constitutively 
active Rac1 (p120KD + Rac1) to rescue the cell cycle distribution of p120-depleted cells (p120KD) was also examined using ﬂ  ow cytometry, as described 
for   Fig. 1 D  . (D) The ability of p120-depleted cells ectopically expressing constitutively active Rac1 (p120KD + Rac1) to grow tumors was examined in 
nude mice. Results represent the mean   ±   SD (error bars) of 10 independent determinations. Note that activated Rac1 is able to rescue the growth of p120-
depleted MDA-MB-231 cells both in vitro and in mice.     741 DUAL ROLE OF   P  120 ON TRANSFORMED CELL GROWTH   • Soto et al. 
  Next, we examined whether E-cadherin expression affects 
Rac1 activity by performing Rac1 pull-down assays for acti-
vated GTP-bound Rac1. Previous studies have indicated that 
Rac1 is activated by E-cadherin  –  mediated cell  –  cell adhesion of 
the ability of a p120-uncoupled E-cadherin mutant (764AAA) to 
suppress MDA-MB-231 growth in soft agar. These data show that 
association with endogenous p120 is necessary for E-cadherin  ’  s 
ability to suppress the growth of MDA-MB-231 cells (  Fig. 4 A  ). 
  Figure 3.       The MAPK pathway is essential for p120-mediated growth effects.   (A) One of the proposed mechanisms by which the ECM is thought to promote 
cell growth is via the Rac1/PAK-mediated constitutive activation of the MAPK pathway. Phosphorylation of Raf (S338) and MEK (S298) at speciﬁ  c serines by 
the Rac1 effector PAK induces complex formation and promotes the constitutive activation of the MAPK  –  ERK pathway in mitogen-stimulated cells, leading to the 
increased expression of cyclin D. (B) Western blots of phosphorylated and total Raf, MEK, and ERK, cyclin D1, and p27 levels in control MDA-MB-231 cells 
(pRS), p120-depleted cells (p120KD), p120-depleted cells expressing murine p120 (KD + mp120), N-terminally deleted p120 (KD +   Δ  N), or constitutively 
active Rac1 (KD + DA-Rac). p120 depletion in MDA-MB-231 cells results in reduced phosphorylation of activating sites in Raf (Ser338), MEK (Ser298), and 
ERK1/2 (Thr202/Tyr204), reduced cyclin D1, and increased p27 levels. These effects are reversed by p120 expression or expression of activated Rac1. 
(C) p120-depleted cells (p120KD) and cells reexpressing p120 (KD + mp120) were grown in soft agar in the presence of either 10   μ  M of the MEK inhibitor 
U0126 or 10   μ  M of its inactive isomer U0124. The inhibition of MEK by U0126 blocks p120-mediated growth in soft agar. Mean   ±   SEM (error bars;   n   = 9). 
(D) Proposed model of p120 action in MDA-MB-231 cells. In MDA-MB-231 cells, p120 promotes growth by activating a Rac1  –  MAPK signaling cascade.     JCB • VOLUME 183 • NUMBER 4 • 2008  742
tissue culture conditions (  Fig. 4 D  ). In contrast, ectopic expression 
of wild-type but not p120-uncoupled E-cadherin potently inhibits 
Ras activation (  Fig. 4 D  ). The data argue that E-cadherin sup-
presses the growth of MDA-MB-231 cells by affecting Ras-MAPK 
signaling at two distinct levels: it suppresses activation of Ras, 
and it blocks the cross talk of Rac1  –  MAPK signaling by inhibit-
ing Rac1. In the absence of E-cadherin (control MDA-MB-231 
cells), p120 promotes Rac1 activation and tumor growth. How-
ever, upon E-cadherin expression, p120 mediates the stabilization 
of E-cadherin complexes, resulting in reduced activation of Ras 
and Rac1 (  Fig. 4 E  ). 
  p120 maintains endogenous E-cadherin 
levels and suppresses the growth of 
MCF7 cells 
  Experiments in MDA-MB-231 cells suggested that endogenous 
p120 can either promote or inhibit tumor growth, depending on 
E-cadherin expression. To further examine this possibility, we 
used MCF7 breast cancer cells, which express endogenous 
E-cadherin ( Fig. 5 A ). 
[ID]FIG5[/ID]   Fig. 5 B  shows that depletion of endogenous 
p120 reduces E-cadherin levels and increases the anchorage-
independent growth of MCF7 cells. This effect of the p120 
shRNA is specifi  c to p120 depletion because the expression of 
epithelial cells (  Nakagawa et al., 2001  ;   Kovacs et al., 2002  ; 
  Fukuyama et al., 2006  ;   Perez et al., 2008  ). However, the expres-
sion of E-cadherin in MDA-MB-231 cells results in an over-
all suppression of basal Rac1 activity (  Fig. 4 B  ). Furthermore, 
in repeated experiments, the ability of E-cadherin to sup-
press Rac1 required p120 binding because a p120-uncoupled 
E-cadherin mutant failed to signifi  cantly inhibit Rac1 (  Fig. 4 B  ). 
In addition, the expression of a nonmembrane-targeted E-cadherin 
tail mutant that can bind p120 but not    -catenin  ( Δ CB; 
 Yanagisawa  and Anastasiadis, 2006  ) also inhibits Rac1 activity 
in MDA-MB-231 cells (  Fig. 4 C  ), suggesting that the adhe-
sive function of E-cadherin is not required for inhibiting Rac1 
activity. These data are consistent with our previous observation 
that p120-mediated Rac1 activation in control MDA-MB-231 
cells requires mesenchymal cadherin association and that 
E-cadherin expression competes p120 away from mesenchymal 
cadherins, leading to their destabilization (  Yanagisawa and 
Anastasiadis, 2006  ). 
  Combined, our data support a model in which p120-medi-
ated Rac1 activation cooperates with Ras-MAPK signaling to in-
duce the transformed growth of MDA-MB-231 cells. Consistent 
with this hypothesis, activated Ras is readily detectable in both 
control (pRS) and p120-depleted cells (p120KD) under normal 
  Figure 4.       E-cadherin expression reverses p120 oncogenic effects and suppresses growth, Rac1, and Ras activity in a p120-dependent manner.   (A) MDA-
MB-231 cells expressing control pRS virus (pRS) or p120-speciﬁ  c shRNA were infected with an LZRS retrovirus expressing wild-type E-cadherin (E-cad and 
E-cad + p120KD, respectively). Control pRS cells were also infected with a virus expressing a p120-uncoupled E-cadherin mutant (764AAA). Polyclonal 
cell populations stably expressing these cadherin constructs were generated after G418 selection. The ability of these cell lines to grow in soft agar was 
tested. E-cadherin expression potently inhibits growth (***, P   <   0.0001; ANOVA;   n   = 9). p120 is required for this because depletion of endogenous p120 
reversed the E-cadherin phenotype, whereas p120-uncoupled E-cadherin failed to inhibit the growth of MDA-MB-231 cells. Mean   ±   SEM (error bars; 
  n   = 9). (B) Levels of total and GTP-bound (active) Rac1 were determined in MDA-MB-231 cells infected with control pRS and LZRS-neo viruses (pRS), p120-
depleted cells (p120KD), or cells reexpressing wild-type (E-cad) or p120-uncoupled E-cadherin (764AAA). E-cadherin  –  expressing cells exhibited lower levels 
of Rac1 activation when compared with control (pRS) or 764AAA-expressing cells. (C) Levels of total and active Rac1 were also tested in MDA-MB-231 
cells infected with control LZRS-neo virus (neo), a virus expressing the     CB E-cadherin mutant, or a virus expressing wild-type E-cadherin (E-cad).     CB is a 
Myc-tagged truncation mutant of the E-cadherin cytoplasmic domain, which binds p120 but not     -catenin. Cells expressing     CB exhibited reduced levels of 
Rac1 activation when compared with LZRS-neo virus control. (D) Levels of total and GTP-bound (active) Ras were also determined in the same cells. E-cadherin  – 
expressing cells (E-cad) exhibit lower Ras activity than control cells (pRS), p120KD cells, or cells expressing the p120-uncoupled E-cadherin mutant 
(764AAA). (E) Proposed model of action. In the absence of E-cadherin (dotted arrow), p120 activates Rac1. In MDA-MB-231 cells expressing exogenous 
E-cadherin (solid arrow), p120 promotes the suppressive function of E-cadherin on both Rac1 and Ras activities.     743 DUAL ROLE OF   P  120 ON TRANSFORMED CELL GROWTH   • Soto et al. 
both the increase in soft agar growth and the increase in MAPK 
signaling downstream of p120 depletion in MCF7 cells are 
mediated by the destabilization of E-cadherin levels (  Fig. 5 B  ). 
Finally, in agreement with the MDA-MB-231 data, the depletion 
of E-cadherin in MCF7 cells increased Rac1 activity (  Fig. 6 C  ). 
A similar increase in the overall Rac1 activity was also observed 
upon E-cadherin depletion in A431 or Caco-2 cells (Fig. S2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200805113/DC1), 
suggesting that this effect of E-cadherin is not restricted to 
MCF7 and MDA-MB-231 cells. 
  Our data raise the possibility that the increased activity of 
Rac1 in p120- or E-cadherin  –  depleted MCF7 cells is responsi-
ble for the increased growth of these cells in soft agar. To test 
this, we stably expressed constitutively active Rac1 in control 
MCF7 cells and tested their ability to grow in soft agar. As can 
be seen in   Fig. 6 D  , the expression of activated Rac1 is not suf-
fi  cient to increase MCF7 anchorage-independent growth. 
  p120 and E-cadherin suppress MCF7 cell 
growth by blocking Ras-MAPK activation 
  The expression of E-cadherin in MDA-MB-231 cells resulted in 
the inhibition of both Rac1 and Ras signaling (  Fig. 4, B and D  ). 
To test the possibility that Ras activation is responsible for the 
increased growth of E-cadherin  –  depleted MCF7 cells, we ini-
tially determined the levels of active Ras in control cells as well 
as cells depleted of endogenous E-cadherin or p120. The deple-
tion of E-cadherin increased Ras activation to a level compara-
ble with that of MCF7 cells overexpressing the RTK Her2, 
murine p120 (p120KD + mp120) inhibits soft agar growth to 
control (pRS) levels. Therefore, p120 suppresses the growth 
of cells expressing either endogenous (MCF7) or exogenous 
(MDA-MB-231) E-cadherin. 
  To determine the mechanism of this p120 effect, we then 
examined the effect of p120 depletion on Rac1/PAK-mediated 
phosphorylation of Raf and MEK as well as levels of cyclins 
and Cdk inhibitors. These data show that p120 depletion in-
duces the phosphorylation of Raf-Ser338 and MEK-Ser298, in-
creases levels of cyclins D1 and E2, and decreases p27/KIP1 
(  Fig. 5 C  ). Consistent with these data, p120 depletion results in 
the activation of Rac1 in MCF7 cells (  Fig. 5 D  ). 
  Depletion of endogenous E-cadherin 
increases the anchorage-independent 
growth of MCF7 cells in a Rac1-
independent manner 
  Given the growth-suppressive effect of E-cadherin in MDA-
MB-231 cells, we postulated that depletion of the endogenous 
E-cadherin in MCF7 cells would result in increased Rac1 – MAPK 
signaling and increased cell growth. As can be seen in   Fig. 6 A  , 
depletion of E-cadherin (E-cadKD) by lentiviral infection of 
MCF7 cells with E-cadherin – specifi  c shRNA (TRCN0000039666) 
increases colony formation in soft agar (identical results were 
also obtained with TRCN0000039664; not depicted) when com-
pared with infected control cells (pLKO). 
[ID]FIG6[/ID]  Furthermore,   Fig. 6 B   
shows that E-cadherin  –  depleted cells exhibit increased phos-
phorylation of Raf-Ser338 and MEK-Ser298, indicating that 
  Figure 5.       p120 increases E-cadherin levels and suppresses growth in MCF7 cells.   (A) Total lysates of MCF7 and MDA-MB-231 cells were immunoblotted 
for E-cadherin and actin as a loading control. MCF7 cells express endogenous E-cadherin. (B) MCF7 cells were infected with control pRS and LZRS-neo 
retroviruses (pRS), p120 shRNA virus together with LZRS-neo (p120KD), or p120 shRNA virus together with a retrovirus expressing murine p120 isoform 
1A (p120KD + mp120). Stable cell populations were generated, and the ability of the cells to grow in soft agar was tested. p120-depleted MCF7 cells 
(p120KD) exhibited low levels of endogenous E-cadherin (bottom) and grew better than control cells (pRS) or cells expressing murine p120 (p120KD + 
mp120). Data are mean   ±   SEM (error bars; *, P   <   0.01; ANOVA;   n   = 6). (C) Lysates of the same cell lines were also subjected to immunoblots for Raf, 
MEK, cyclins D1 and E2, and actin (control). p120-depleted MCF7 cells exhibited higher levels of known PAK1 phosphorylation sites in Raf (Ser338) and 
MEK (Ser298) than in control (pRS) or murine p120 reconstituted cells (p120KD + mp120). In accordance with this ﬁ  nding, the levels of cyclins D1 and E2 
were also elevated in these cells. (D) Finally, the levels of total and GTP-bound (active) Rac1 activity were also determined using a speciﬁ  c pull-down assay. 
Consistent with the previous data, p120-depleted cells have higher Rac1 activity than control cells or cells expressing murine p120.     JCB • VOLUME 183 • NUMBER 4 • 2008  744
p120-mediated stabilization of mesenchymal cadherins and ac-
tivation of Rac1, and, subsequently, Rac1-mediated constitutive 
activation of Ras-MAPK signaling and increased tumor growth. 
  Discussion 
  p120 catenin is known to regulate the stabilization of cadherins 
at the plasma membrane and the activation of Rho family GT-
Pases. Several recent studies indicate that p120 regulates the 
sessile versus motile behavior of cells by reorganizing the cyto-
skeleton and promoting either cell  –  cell adhesion or cell migra-
tion (for review see   Anastasiadis, 2007  ). Nonetheless, both 
cadherin-mediated cell  –  cell contact and Rho GTPase signaling 
can also regulate cell growth, suggesting a potential growth reg-
ulatory role for p120. This notion was further supported by the 
observation that conditional p120 knockout in either the sali-
vary gland or the skin induces hyperproliferation (  Davis and 
Reynolds, 2006  ;   Perez-Moreno et al., 2006  ). Given that mis-
regulation of both E-cadherin and p120 are common events in 
tumor progression, we examined the potential effects of p120 on 
tumor cell growth in the presence or absence of E-cadherin. Our data 
which is used here as a positive control (  Fig. 7 A  ). 
[ID]FIG7[/ID]  Importantly, 
Her2 overexpression induced anchorage-independent growth 
of MCF7 cells to a level comparable with that of cells de-
pleted of endogenous E-cadherin (Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200805113/DC1). The de-
pletion of endogenous p120 strongly inhibited the cellular 
levels of E-cadherin and induced Ras activation, which was 
readily inhibited by the reexpression of murine p120 (  Fig. 7 A  ). 
These data argue that endogenous E-cadherin suppresses MCF7 
cell growth by inhibiting Ras signaling and that p120 inhib-
its the growth of these cells by promoting the stabilization of 
E-cadherin complexes. 
  Finally, we used the MEK inhibitor U0126 to test the in-
volvement of the Ras  –  MAPK  –  ERK signaling pathway on the 
growth of E-cadherin  –  depleted MCF7 cells in soft agar. As can 
be seen in   Fig. 7 B  , inhibition of MEK completely abrogates the 
ability of E-cadherin  –  depleted MCF7 cells to grow colonies 
in soft agar. Combined, the data indicate that p120 cooperates 
with E-cadherin to suppress Ras signaling events and inhibit 
the growth of epithelial cells (  Fig. 8  ). 
[ID]FIG8[/ID]  The loss of E-cadherin 
expression or function results in increased Ras activation, 
  Figure 6.       Depletion of endogenous E-cadherin in MCF7 
cells increases anchorage-independent growth.   (A) Con-
trol MCF7 cells were infected with control pLKO lentivirus 
or lentivirus expressing E-cadherin  –  speciﬁ  c shRNA. After 
the selection of stable polyclonal cell lines in puromycin, 
the ability of cell lines to form colonies in soft agar was 
tested. Cells expressing low levels of E-cadherin (E-cadKD) 
grow better in soft agar than control cells (pLKO). Data 
are mean   ±   SEM (error bars; **, P   <   0.001; Student  ’  s 
  t   test;   n   = 6). Identical results were also obtained with 
a separate shRNA construct targeting E-cadherin (not 
depicted). (B) Lysates of control and E-cadherin  –  depleted 
cells (E-cadKD) were immunoblotted for E-cadherin, active 
and total Raf and MEK, and cyclin D1 as well as actin 
as a loading control. E-cadherin  –  depleted cells exhibited 
increased phosphorylation of activating sites on both Raf 
(Ser338) and MEK (Ser298). In agreement with these 
results, cyclin D1 levels were also higher. (C) Levels of 
GTP-bound (active) and total Rac1 were also determined. 
Consistent with the previous data, E-cadherin  –  depleted 
cells exhibited higher levels of activated Rac1. (D) To test 
the hypothesis that increased Rac1 activation is respon-
sible for the increased ability of E-cadherin  –  deﬁ  cient cells 
to grow in soft agar, we infected control MCF7 cells with 
a retrovirus expressing a constitutively active V12-Rac1 
mutant (DA-Rac1). The data show that Rac1 activation is 
not sufﬁ  cient to increase the ability of MCF7 cells to grow 
in soft agar. Mean   ±   SEM (error bars;   n   = 9).     745 DUAL ROLE OF   P  120 ON TRANSFORMED CELL GROWTH   • Soto et al. 
  Previous experiments on the mechanism by which anchor-
age to the ECM induces cell growth have implicated integrin-
mediated Rac1 activation ( Frost et al., 1997 ;  Coles and Shaw, 2002 ; 
  Eblen et al., 2002  ;   Slack-Davis et al., 2003  ;   Beeser et al., 2005  ). 
Through its downstream effector kinase PAK, Rac1 induces the 
phosphorylation of critical serines on Raf and MEK, promoting 
complex formation and recruitment of ERK. Thus, Rac1 cooper-
ates with other growth signals in the propagation of Ras-MAPK 
signaling. Transformed cells that can grow anchorage indepen-
dently would be expected to have developed mechanisms to over-
come the need for this integrin-mediated signaling. Our data show 
that p120-mediated activation of Rac1 is one of the mechanisms 
that E-cadherin  –  defi  cient tumor cells use to grow under condi-
tions of anchorage independence. We have shown previously that 
p120 induces Rac1 in these cells via its association with mesen-
chymal cadherins (  Yanagisawa and Anastasiadis, 2006  ). We 
have also shown that reexpression of E-cadherin results in 
the preferential association of p120 with E-cadherin complexes 
and the destabilization of mesenchymal cadherins (  Yanagisawa 
and Anastasiadis, 2006  ). Consistent with these observations, ecto-
pic expression of E-cadherin in MDA-MB-231 cells results in a 
marked reduction of Rac1 activation and potently inhibits anchor-
age-independent cell growth. Remarkably, the growth-suppressive 
function of E-cadherin requires p120 because either p120 deple-
tion or mutation of the p120-binding site of E-cadherin abro-
gates E-cadherin  ’  s ability to inhibit the growth of cells in soft agar 
(  Fig. 4 A  ). Therefore, p120 induces the transformed growth of 
E-cadherin – defi  cient cells by activating a Rac1  –  MAPK signaling 
pathway normally activated by the adhesion of cells to the ECM, 
whereas E-cadherin (stabilized by p120 association) selectively 
and potently inhibits the transformed growth of epithelial cells. 
reveal that endogenous p120 induces the anchorage-independent 
transformed growth of E-cadherin  –  defi  cient cells, whereas it pro-
motes cadherin-mediated growth suppression in cells express-
ing endogenous or exogenous E-cadherin. 
  The loss of E-cadherin expression or function is a com-
mon event during tumor progression (  Yap, 1998  ;   Nollet et al., 
1999  ). E-cadherin is widely considered to be a suppressor of tu-
mor cell invasion, and several studies have indicated that its re-
expression in E-cadherin  –  defi  cient carcinomas reverts cells to a 
less invasive, less aggressive phenotype (  Behrens et al., 1989  ; 
  Frixen et al., 1991  ;   Vleminckx et al., 1991  ;   Perl et al., 1998  ; 
  St. Croix et al., 1998  ;   Gottardi et al., 2001  ;   Yanagisawa and 
Anastasiadis, 2006  ). Furthermore, a more traditional tumor-
suppressing function for E-cadherin has also been suggested 
( St. Croix et al., 1998 ;  Gottardi et al., 2001 ;  Stockinger et al., 2001 ). 
The loss of E-cadherin function results in tissue dysfunction 
and often cell death (  Ohsugi et al., 1997  ;   Boussadia et al., 2002  ; 
  Tinkle et al., 2004  ). However, several modifi  cations, including 
reduced p53 function, activation of Ras, or SV40 T antigen ex-
pression, rescue this phenotype and cooperate with E-cadherin 
loss to induce both the growth and dissemination of epithelial 
tumors (  Perl et al., 1998  ;   Yamaguchi et al., 2004  ;   Derksen et al., 
2006  ;   Igaki et al., 2006  ). In this study, we show that in the ab-
sence of E-cadherin, p120 promotes tumor cell growth on plas-
tic, in soft agar, as well as after tumor cell injection into nude 
mice. The reduced growth of p120-depleted MDA-MB-231 
cells is not related to decreased Ras activation (  Fig. 4 D  ) but to 
reduced activity of Rac1 and reduced cross talk between Rac1 
and Ras-MAPK signaling. Indeed, the expression of an acti-
vated Rac1 mutant rescues both the signaling and the growth of 
p120-depleted cells in vitro and in vivo. 
  Figure 7.       E-cadherin suppresses growth by blocking Ras-MAPK activation in a p120-dependent manner.   (A) Levels of total and GTP-bound (active) Ras 
were determined in MCF7 cells infected with control pRS and LZRS-neo viruses (pRS), p120-depleted cells (p120KD), p120-depleted cells expressing 
murine p120 (p120KD + mp120), E-cadherin  –  depleted cells (E-cadKD), or cells overexpressing the RTK Her2 (as a positive control). Both E-cadherin  –   and 
p120-depleted cells exhibited high levels of Ras activation, which are comparable with the levels induced by overexpression of Her2. The expression 
of murine p120 in p120-depleted cells potently blocks Ras activation. Levels of p120 and E-cadherin as well as actin loading controls are shown in the 
bottom panels. Note that upon p120 depletion, E-cadherin levels are drastically reduced but reinstated by exogenous expression of murine p120. 
(B) E-cadherin  –  depleted cells (E-cadKD) and cells expressing control pLKO lentivirus (pLKO) were grown in soft agar in the presence of either 10   μ  M of the 
MEK inhibitor U0126 or 10   μ  M of its inactive isomer U0124. Inhibition of MEK by U0126 blocks the ability of E-cadherin  –  deﬁ  cient MCF7 cells to grow 
in soft agar, suggesting the involvement of the MAPK pathway. Mean   ±   SEM (error bars;   n   = 9).     JCB • VOLUME 183 • NUMBER 4 • 2008  746
and Ridley, 2004  ;   Yanagisawa et al., 2004  ). p120 overexpres-
sion experiments have suggested that this association can in-
duce the stabilization of cyclin E – Cdk2 complexes during mitosis, 
inhibit cell growth, and increase polyploidy (  Chartier et al., 2007  ). 
The observation that the microtubule-uncoupled (  Yanagisawa 
et al., 2004  ) p120   Δ  N mutant can induce anchorage-independent 
growth in our cells suggests that this mechanism of growth reg-
ulation by p120 cannot account for our effects. Finally, using a 
Rho-uncoupled p120 mutant (  Fig. 2 B  ) or constitutively active 
and dominant-negative RhoA mutants (not depicted), we found 
no evidence that either p120 or E-cadherin  –  mediated MDA-
MB-231 growth effects were mediated by changes in RhoA 
signaling. However, several studies indicate that RhoA and its 
downstream effector Rho kinase can also promote sustained 
ERK/MAPK activation and cell cycle progression of mitogen-
stimulated cells, especially fi  broblasts (for review see   Coleman 
et al., 2004 ). Therefore, it is possible that, as with Rac1 and RhoA, 
the ability of p120 to affect growth is context dependent. 
  Cellular context is also likely critical for the ability of p120 
and E-cadherin to regulate Rac1 activity. Previous studies using 
primarily MDCK cells and calcium switch to induce cell  –  cell 
adhesion have shown that E-cadherin trans-interaction can in-
duce Rac1 activation (  Nakagawa et al., 2001  ;   Kovacs et al., 
2002  ;   Fukuyama et al., 2006  ;   Perez et al., 2008  ). Increased cell 
  The aforementioned interpretation is also in agreement 
with experiments in MCF7 cells, which express endogenous 
E-cadherin. The depletion of p120 in these cells sharply reduces 
the levels of E-cadherin and induces anchorage-independent 
growth, phenocopying the effect of p120 depletion in MDA-
MB-231 cells that ectopically express wild-type E-cadherin. 
Furthermore, the depletion of endogenous E-cadherin mimics 
the effects of p120 depletion on intracellular signaling and 
anchorage-independent growth. Therefore, in E-cadherin – expressing 
cells, p120 affects growth by promoting the tumor-suppressive 
function of E-cadherin complexes. The exact mechanism by 
which E-cadherin suppresses cell growth is unclear. However, 
several recent studies implicate     -catenin and either its nuclear 
signaling or the negative regulation of RTK signaling (  Gottardi 
et al., 2001  ;   Stockinger et al., 2001  ;   Qian et al., 2004  ;   Perrais 
et al., 2007  ). Although we have not specifi  cally addressed this 
question, our data show that E-cadherin exerts a potent inhibi-
tory effect on Ras activation, which is consistent with an in-
hibitory effect on cadherin-associated RTKs. Interestingly, our 
experiments in MDA-MB-231 cells show that p120 does not af-
fect Ras activation in the absence of E-cadherin; however, it is 
essential for E-cadherin  –  mediated suppression of Ras. 
  In addition to binding cadherins, p120 can also associate 
with microtubules and centrosomes (  Chen et al., 2003  ;   Franz 
  Figure 8.       Proposed model of p120 action.   The presence of E-cadherin causes the potent inhibition of Ras and Rac1, inhibits MAPK/ERK signaling, reduces 
cyclin D1, and promotes increased levels of p27, thus blocking cell growth. Under these conditions, p120 promotes the stabilization of E-cadherin com-
plexes and their ability to suppress Ras. p120 recruitment by E-cadherin also decreases mesenchymal cadherin stability and function, resulting in reduced 
Rac1 activation. However, upon E-cadherin loss during tumor progression, the negative regulation of Ras is relieved. Under these conditions, endogenous 
p120 induces transformed cell growth by activating Rac1 and inducing the Rac1-dependent, PAK-mediated phosphorylation of Raf and MEK, which result 
in the constitutive, anchorage-independent activation of the Ras  –  MAPK  –  ERK signaling pathway. Dotted arrows denote potential Ras-mediated signaling 
events leading to anchorage-independent growth.     747 DUAL ROLE OF   P  120 ON TRANSFORMED CELL GROWTH   • Soto et al. 
  Materials and methods 
  Cell cultures, infections, and transfections 
  Cells were cultured in DME supplemented with 10% heat-inactivated FBS 
(Invitrogen), 100 U/ml penicillin, and 100   μ  g/ml streptomycin (Mediatech). 
shRNA expression was achieved by retroviral (pRS) or lentiviral (pLKO) infec-
tion, and polyclonal stable cell lines were generated after selection in 5   μ  g/ml 
puromycin. Cell lines reexpressing the indicated proteins were infected with 
the LZRS-neo retrovirus and selected with 1 mg/ml G418. pRS and LZRS am-
photropic retroviruses were produced as described previously (  Davis et al., 
2003  ). Lentivirus was generated using the standard protocols set forth by the 
Mayo Clinic Comprehensive Cancer Center RNA Interference Technology 
Resource. Conﬂ  uence for all experiments was between 30 and 50%, unless 
otherwise noted. 
  Constructs 
  LZRS  –  mp120 isoform 1A-neo, LZRS  –  mp120 isoform   Δ  N-neo, LZRS-DA-Rac1-
neo, LZRS  –  wild type  –  E-cadherin  –  neo, and LZRS-764AAA-neo were described 
previously (  Davis et al., 2003  ;   Yanagisawa and Anastasiadis, 2006  ). The 
pRS vector was a gift from R. Agami (The Netherlands Cancer Institute, 
Amsterdam, Netherlands). pRS human p120 shRNA was also described 
previously (  Davis et al., 2003  ). The pLKO and pLenti-human E-cadherin 
shRNA (TRCN0000039663  –  67) were purchased from the Mission RNAi 
Consortium shRNA collection (Sigma-Aldrich) and obtained from the Mayo 
Clinic Comprehensive Cancer Center RNA Interference Technology Re-
source. TRCN0000039666 achieved the best E-cadherin KD and was used 
in most experiments followed by TRCN0000039664, which was used to 
validate results. 
  Western blotting 
  Western blotting procedures were conducted as described previously (  Ireton 
et al., 2002  ). Primary antibodies used were as follows: anti  –  c-Raf, cyclins D1 
and E2, MEK1, p44/42 MAPK, phospho-p44/42 MAPK (Thr202/Tyr204), 
phospho-MEK1 (Ser298), phospho  –  c-Raf (Ser338), Ras, and p27/KIP1 anti-
bodies were all purchased from Cell Signaling Technology; anti-p120 mAb 
15D2 was purchased from Invitrogen; actin (C-11), RhoA (26C4), and the 
HRP-conjugated secondary antibodies (mouse, rabbit, and goat) were pur-
chased from Santa Cruz Biotechnology, Inc.; anti-Rac1 and anti  –  E-cadherin 
were purchased from BD. 
  Cell growth assay 
  Cells growing under standard conditions were harvested using Cell Strip-
per (Mediatech) to prevent the proteolytic degradation of cadherins, 
counted, and resuspended in complete media at 1.5   ×   10 
4   cells per well 
in 24-well plates. At the indicated times after plating, cells were trypsin-
ized, mixed with trypan blue at a 1:1 dilution, and counted using a hema-
cytometer. All experiments were performed in triplicate. Data are expressed 
as mean   ±   SEM. 
  Cell cycle analysis 
  2   ×   10 
6   cells were ﬁ  xed with cold ethanol for 1 h at 4  °  C. Samples were 
washed with PBS, treated with RNase A solution (1 mg/ml in 0.1% 
sodium citrate), and stained with propidium iodide before ﬂ  ow cytometry 
analysis was conducted at the Mayo Clinic Flow Cytometry/Optical Mor-
phology Resource. 
  Soft agar growth assays 
  Soft agar growth assays were performed as previously described (  Murray 
et al., 2004  ). In brief, 10 
4   cells were suspended in DME supplemented with 
10% heat-inactivated FBS, penicillin/streptomycin, and 1.5% low melting 
point agarose (SeaKem LE Agarose). Suspensions were plated on 60-mm 
culture dishes containing a layer of DME supplemented with 10% heat-
inactivated FBS, penicillin/streptomycin, and 1.5% low melting point aga-
rose. After 14  –  21 d in culture, colonies were stained with a 0.005% crystal 
violet solution and counted. When indicated, 10   μ  M of control (U0124) or 
10   μ  M of MEK inhibitor (U0126) was added to the suspended cells and 
fed every other day with media containing the respective compounds. 
  Rac, Rho, and Ras assays 
  Cells were plated on 100-mm dishes under normal culture conditions (DME 
supplemented with 10% heat-inactivated FBS and penicillin/streptomycin). 
RhoA, Rac1, and Ras activity was assessed as previously described 
(  Anastasiadis et al., 2000  ). Lysates were collected by adding 1 ml of lysis 
buffer (20 mM Hepes, pH 7.5, 0.5% NP-40, 100 mM NaCl, 0.2% deoxy-
cholic acid, 10% glycerol, and 10 mM MgCl  2  ) supplemented with protease 
confl  uence was shown to activate Rac1 in MDCK and 293 cells 
(  Noren et al., 2001  ). Surprisingly, in this study, we show that the 
overall Rac1 activity is signifi  cantly reduced in E-cadherin  –
  expressing MDA-MB-231 cells. Consistent with this, the deple-
tion of endogenous E-cadherin increases Rac1 activity in MCF7 
(breast), A431 (squamous), and Caco-2 (intestinal epithelial) cells. 
These data suggest the existence of cell-specifi  c differences in 
cadherin signaling, which are likely important for normal cell 
function and tumor progression. Previous data have argued that 
E-cadherin  –  dependent activation of Rac1 requires the EGFR 
(  Betson et al., 2002  ). However, E-cadherin clustering can also 
potently inhibit several RTKs, including EGFR (  Qian et al., 
2004  ), suggesting that the interplay between cadherins and RTKs 
is critical for E-cadherin effects on Rac1. In the case of MDA-
MB-231 cells, Rac1 activation is induced by p120 binding to mes-
enchymal cadherins and is inhibited by the recruitment of p120 
away from these complexes. We postulate that the binding of 
mesenchymal cadherins to a diverse group of RTKs and their 
reduced ability to cluster into adhesive complexes when com-
pared with E-cadherin may result in an increased overall activa-
tion of Rac1. Therefore, the effects of E-cadherin on Rac1 may 
depend on the complement of classical cadherins and associated 
RTKs expressed in a given cell. Future experiments using cad-
herin cytoplasmic domain mutants or chimeras of E-cadherin 
and mesenchymal cadherin will be important for elucidating the 
differential mechanisms by which E-cadherin or mesenchymal 
cadherin signals toward Rac1. 
  In summary, our data support an unexpected dual role of 
p120 on the transformed growth of tumor cells ( Fig. 8 ). In the pres-
ence of E-cadherin expression, p120 acts to stabilize E-cadherin 
complexes and to promote their tumor-suppressive function, 
potently inhibiting Ras activation. Upon E-cadherin loss during 
tumor progression, the negative regulation of Ras is relieved; 
under these conditions, endogenous p120 induces transformed 
cell growth by activating Rac1 and the subsequent phosphoryla-
tion of Raf and MEK, which result in the constitutive, anchorage-
independent activation of the Ras – MAPK – ERK signaling pathway. 
These data have signifi  cant implications for tumor biology and 
cancer treatment. The status of E-cadherin has long been associ-
ated with a worse prognosis and aggressive disease. We have re-
cently shown that targeting p120 function prevents the invasive 
behavior of E-cadherin  –  defi  cient carcinomas (  Yanagisawa and 
Anastasiadis, 2006  ;   Yanagisawa et al., 2008  ). The current data 
suggest that understanding and targeting the ability of p120 to 
activate Rac1 may also block the transformed growth of these 
E-cadherin – defi  cient cells. Recent studies have shown that tumors 
exhibiting an epithelial to mesenchymal transition, and thus lack-
ing E-cadherin expression, are more resistant to treatment with 
EGFR inhibitors (  Yauch et al., 2005  ;   Witta et al., 2006  ;   Black 
et al., 2008  ). These data raise the possibility that upon E-cadherin 
loss, multiple mechanisms leading to Ras activation are induced. 
This possibility is supported by the observation that multiple RTKs 
can be inhibited by E-cadherin expression (  Qian et al., 2004  ). 
Therefore, in E-cadherin  –  defi  cient cells, specifi  c RTK inhibitors 
may fail to inhibit Ras activation, whereas endogenous p120 could 
still promote the constitutive activation of MAPK signaling and 
transformed growth via Rac1 activation. JCB • VOLUME 183 • NUMBER 4 • 2008  748
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